£110.60

Springer - Resistance to Immunotherapeutic Antibodies in Cancer

Price data last checked 79 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£111 today · previous high £111 · all-time low £110

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 12 days • 12 data points (No recent data available)

Historical
Generating forecast...
£110.60 £109.53 £109.77 £110.00 £110.23 £110.46 £110.70 11 April 2026 13 April 2026 16 April 2026 19 April 2026 22 April 2026

Price Distribution

Price distribution over 12 days • 2 price levels

Days at Price
Current Price
11 days 1 day · current 0 3 6 8 11 £110 £111 Days at Price

Price Analysis

Most common price: £110 (11 days, 91.7%)

Price range: £110 - £111

Price levels: 2 different prices over 12 days

Description

Traditional cancer treatments like chemotherapy, radiation, and hormonal therapy are effective but often lack selectivity and can be highly toxic to the body. This volume from the Resistance to Targeted Anti-Cancer Therapeutics series explores the promising alternative of antibody-mediated anti-cancer therapy. Monoclonal antibodies (mAbs) offer a more selective approach by targeting specific cell receptors to destroy malignant tumor cells and prevent further growth. This method is less toxic and holds the potential to reverse existing resistance to drugs and radiation. This book provides a deep look into the mechanisms of monoclonal antibodies and the strategies used to overcome resistance in cancer treatment. It is an essential resource for understanding how targeted therapies can change the landscape of oncology by providing more precise and effective options for patient care.

Key Features

Explores antibody-mediated anti-cancer therapy as a selective and less toxic alternative to traditional chemotherapy and radiation.

Provides detailed information on how monoclonal antibodies (mAbs) work to destroy malignant tumor cells.

Discusses methods for blocking specific cell receptors to prevent tumor growth effectively.

Examines the potential for monoclonal antibodies to reverse resistance to existing drug and radiation treatments.

Part of the specialized Resistance to Targeted Anti-Cancer Therapeutics series published by Springer.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
22 August 2015
Listed Since
22 August 2015

Barcode

No barcode data available

Similar Products You Might Like

Springer - Resistance to Immunotherapeutic Antibodies in Cancer
99% match

Springer - Resistance to Immunotherapeutic Antibodies in Cancer

Springer

£107.61 17 Apr 2026
Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
97% match

Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives

Academic Press

£92.89 04 Jul 2026
Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)
96% match

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Humana

£69.36 07 Jul 2026
Academic Press - Multifaceted Role of IL-1 in Cancer and Inflammation
96% match

Academic Press - Multifaceted Role of IL-1 in Cancer and Inflammation

Academic Press

£114.57 18 Apr 2026
Nijkamp and Parnham's Principles of Immunopharmacology
96% match

Nijkamp and Parnham's Principles of Immunopharmacology

Springer

£87.32 30 Apr 2026
Immune Aspects of Biopharmaceuticals and Nanomedicines (Jenny Stanford Series on Nanomedicine)
96% match

Immune Aspects of Biopharmaceuticals and Nanomedicines (Jenny Stanford Series on Nanomedicine)

Taylor & Francis

£328.92 10 Jun 2026
Springer Progress in Cancer Immunotherapy: 909 - Academic Book
96% match

Springer Progress in Cancer Immunotherapy: 909 - Academic Book

Springer

£113.77 23 Apr 2026
Cancer Immunotherapy: Immune Suppression and Tumor Growth
96% match

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Academic Press

£77.00 03 Jul 2026
Basic Immunology: Functions and Disorders of the Immune System
96% match

Basic Immunology: Functions and Disorders of the Immune System

Elsevier

£51.39 16 Mar 2026
Humana Cancer Immunosurveillance: Methods and Protocols 1884
96% match

Humana Cancer Immunosurveillance: Methods and Protocols 1884

Humana

£104.04 18 Apr 2026
Springer - Innate Immune Regulation and Cancer Immunotherapy
96% match

Springer - Innate Immune Regulation and Cancer Immunotherapy

Springer

£108.78 23 Apr 2026
Springer - Tumor-Induced Immune Suppression Book
96% match

Springer - Tumor-Induced Immune Suppression Book

Springer

£129.22 05 May 2026
Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)
96% match

Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)

Humana

£89.34 03 Jul 2026
Cancer Immunotherapy: Immune Suppression and Tumor Growth
96% match

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Academic Press

£78.99 03 Jul 2026
Regulatory B Cells: Methods and Protocols: 1190 (Methods in Molecular Biology)
96% match

Regulatory B Cells: Methods and Protocols: 1190 (Methods in Molecular Biology)

Humana

£85.50 09 Jul 2026
Academic Press Advances in Immunology (Volume 86) - Book
96% match

Academic Press Advances in Immunology (Volume 86) - Book

Academic Press

£154.58 28 Apr 2026
Targeted Cancer Immune Therapy
96% match

Targeted Cancer Immune Therapy

Springer

£143.98 13 Jun 2026
Humana Immune Receptors: Methods and Protocols 748 Book
96% match

Humana Immune Receptors: Methods and Protocols 748 Book

Humana

£100.81 14 Apr 2026
Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)
96% match

Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)

Elsevier

£69.09 08 Jul 2026
Nitric Oxide and Cancer: Pathogenesis and Therapy
96% match

Nitric Oxide and Cancer: Pathogenesis and Therapy

Springer

£107.98 17 Jun 2026
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)
96% match

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)

Springer

£176.00 09 Apr 2026
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research)
96% match

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research)

Springer

£165.42 03 Jul 2026
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
96% match

Cancer Immunology: Bench to Bedside Immunotherapy of Cancers

Springer

£156.60 13 Jun 2026
Springer Mathematical Modelling of Immune Response - Vol 395
96% match

Springer Mathematical Modelling of Immune Response - Vol 395

Springer

£72.77 28 Apr 2026